Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126735
Filing Date
2024-11-14
Accepted
2024-11-14 07:24:19
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20240930.htm   iXBRL 10-Q 2035251
2 EX-31.1 ivvd-ex31_1.htm EX-31.1 17795
3 EX-32.1 ivvd-ex32_1.htm EX-32.1 10383
  Complete submission text file 0000950170-24-126735.txt   7908798

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20240930.xsd EX-101.SCH 1211011
72 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20240930_htm.xml XML 1239774
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 241457177
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)